Debrisoquine and mephenytoin oxidation in Sinhalese: a population study - Wikidata - awgldk - TriplyDB

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

http://www.wikidata.org/entity/Q34346631

about

Pharmacogenetics and psychopharmacotherapy.Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study.Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Genetic variants in the cytochrome P450 2D6 gene in the Sri Lankan population.Genetic polymorphism of CYP2D6 in a keralite (South India) population.Genetic polymorphism of CYP2D6 in Tamil population.Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjects.

P2860

Q33962212-101B3A62-BD44-4DDC-836E-F0DC36C72E61 Q34347620-FBC3991F-20D0-46F1-9541-D5EF6476EE15 Q34909452-0B52C647-9D4B-4474-AB09-FA59DFF2DFF4 Q37693445-C94FCDE4-A4F6-480F-8C35-63336E8BA5A4 Q38260323-15648C1C-3B2E-4B8A-97F6-D2EBD360BA98 Q38616806-4868FC8E-730B-4D03-BDAD-396060B1FFA0 Q41881718-1B0A6A55-4DB6-4AC6-9E23-D5B12F8AE178 Q42561477-BF850CD7-AE24-4A4E-86BF-17C1163ACDE3 Q43569136-55740B9B-B767-4E2C-BCFF-F6EE733C7474 Q53885796-B7C59FE5-9613-49E5-BD89-7294C91B1FBE

P2860

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

http://www.wikidata.org/entity/Q34346631

description

1994 nî lūn-bûn

@nan

1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@ast

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@en

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@nl

type

label

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@ast

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@en

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@nl

prefLabel

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@ast

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@en

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@nl

P1433

Q34346631-BCB7BB12-77F4-4C7F-A0F7-F9C07D1344E2

P1476

Q34346631-AA3CB6F5-4B6A-4CB7-8B00-E98063B39E54

P2093

Q34346631-2F157B19-B190-4B84-98EA-412825485A94

Q34346631-48C55C40-7716-41E5-9C07-C5596B161850

Q34346631-5C644F02-592B-475E-90C5-D8E0C2740397

Q34346631-782141C8-50F3-4950-8A5C-147449E7603B

Q34346631-9380BE5D-D31A-4128-80FB-F4C169B76735

Q34346631-A2380986-3919-443C-B91F-B0702FA9F460

P2860

Q34346631-150B03E0-9930-4DC0-9CB8-F608147A6946

Q34346631-1EF07779-8CAB-48FE-8733-928ACFB27CC2

Q34346631-240B3F46-13CB-4DE4-AA61-8F3E0234CED5

Q34346631-42E5BA93-3050-435F-8444-6B97FD1F7E29

Q34346631-47DA4694-44D0-47D7-88D3-B6B9A8FB7757

Q34346631-5CA82C42-3246-4F11-A655-3CB1A9F08491

Q34346631-91E5C5FB-85CB-4D17-A52F-FF11DC4B2219

Q34346631-A900D242-5450-4899-8116-32A0F50B8382

Q34346631-DF7A30F1-8D49-47EB-92F1-06DE571459A0

Q34346631-EDEC31DE-31F7-4D8A-9758-34CD46DC7A99

P304

Q34346631-B4D07177-E5B6-4871-9AC9-BC518FC37768

P31

Q34346631-131FB62B-F9F9-484E-A2DF-C1CFA79C7A28

P356

Q34346631-7D8216DD-302E-486C-B609-109D91784322

P407

Q34346631-3E1D41DF-69D7-4DB8-93B8-B601EB2D48C6

P433

Q34346631-AB12B05B-75BB-4489-96B9-7160132B9ED0

P478

Q34346631-1683C2B1-2E2D-405E-8200-8B3AEB3D82FA

P577

Q34346631-D33297DF-4F14-4A3F-9DA2-B8C58C46A9D0

P5875

Q34346631-303A4D86-497C-4A31-9581-95429D06BFC1

P698

Q34346631-92C0309C-9A1C-4368-A66D-7E78B977DB42

P932

Q34346631-5254BAEE-4B88-4288-AF91-A17F08879D78

P356

J.1365-2125.1994.TB04384.X

P1433

British Journal of Clinical Pharmacology

P1476

Debrisoquine and mephenytoin oxidation in Sinhalese: a population study

@en

P2093

Jayakody RL

http://www.w3.org/2001/XMLSchema#string

Lennard MS

http://www.w3.org/2001/XMLSchema#string

Smith CA

http://www.w3.org/2001/XMLSchema#string

Tucker GT

http://www.w3.org/2001/XMLSchema#string

Weerasuriya K

http://www.w3.org/2001/XMLSchema#string

Wolf CR

http://www.w3.org/2001/XMLSchema#string

P2860

Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data

Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing.

Blood genetic markers in Sri Lankan populations--reappraisal of the legend of Prince Vijaya.

Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies

Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations.

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.

Genetic polymorphism of S-mephenytoin hydroxylation.

Metabolic polymorphisms.

Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.

P304

466-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1994.TB04384.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

1994-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15304820

http://www.w3.org/2001/XMLSchema#string

P698

7893590

http://www.w3.org/2001/XMLSchema#string

P932

1364882

http://www.w3.org/2001/XMLSchema#string